Fortitude Family Office’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
AAA
VCM
PAI
6CM
Fortitude Family Office's ANAB Position: Q1 2026 in Review
Fortitude Family Office opened a new position in AnaptysBio (ANAB) in Q1 2026: 8 shares worth $444. The stake represents ﹤0.01% of the portfolio and ranks #1769 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in ANAB as recently as Q3 2024.
Fortitude Family Office first reported a position in ANAB in Q2 2024 and has held it in 3 quarters since. The position peaked at $1.04K in Q3 2024. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.
- Fortitude Family Office held 8 shares of AnaptysBio worth $444 as of Q1 2026.
- AnaptysBio was a new Fortitude Family Office position in Q1 2026.
- AnaptysBio made up ﹤0.01% of Fortitude Family Office's portfolio in Q1 2026, its #1769 holding.
- Fortitude Family Office first reported a position in AnaptysBio in Q2 2024 and has held it in 3 quarters since.
- Fortitude Family Office's AnaptysBio position peaked at $1.04K in Q3 2024.
- 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.
Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.